689 related articles for article (PubMed ID: 29210632)
1. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
2. Role of matrix metalloproteinases in renal pathophysiologies.
Catania JM; Chen G; Parrish AR
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F905-11. PubMed ID: 17190907
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
Zakiyanov O; Kalousová M; Zima T; Tesař V
Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
[TBL] [Abstract][Full Text] [Related]
4. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology].
Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Rybi-Szumińska A; Kołodziejczyk Z
Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
Parrish AR
Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases: pathways of induction by bioactive molecules.
Tsuruda T; Costello-Boerrigter LC; Burnett JC
Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in inflammatory pathologies of the horse.
Clutterbuck AL; Harris P; Allaway D; Mobasheri A
Vet J; 2010 Jan; 183(1):27-38. PubMed ID: 19022687
[TBL] [Abstract][Full Text] [Related]
9. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
[TBL] [Abstract][Full Text] [Related]
10. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
[TBL] [Abstract][Full Text] [Related]
13. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
Fink K; Boratyński J
Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
[TBL] [Abstract][Full Text] [Related]
15. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
17. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases.
Abraham D; Ponticos M; Nagase H
Curr Vasc Pharmacol; 2005 Oct; 3(4):369-79. PubMed ID: 16248781
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
Varghese S
Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
[TBL] [Abstract][Full Text] [Related]
20. TIMPs as multifacial proteins.
Lambert E; Dassé E; Haye B; Petitfrère E
Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]